Technology areas: Biotechnology & Pharmaceuticals • Communications
10 pending office actions • 8 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Element Biosciences Inc. has 10 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 9 distinct examiners across 8 distinct art units, indicating a distributed portfolio with some repeated examiner and art-unit assignments.
HUTSON, RICHARD G is the busiest examiner, with 2 pending matters. Those matters offer the clearest opportunity for coordinated review, while the remaining actions call for examiner- and art-unit-specific analysis.
Counsel should combine centralized docket oversight with technical issue mapping across the biotechnology matters. Shared positions may be useful where disclosures overlap, but the assignment pattern supports testing each argument against the particular examination record.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (20%) |
| §102 only | 1 (10%) |
| §112 only | 1 (10%) |
| Double-patenting only | 1 (10%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUTSON, RICHARD G | 2 | 65.1% | +52.9% |
| HSIEH, PING Y | 1 | 79.1% | +15.5% |
| COUSO, JOSE L | 1 | 90.2% | +8.4% |
| BOOSALIS, FANI POLYZOS | 1 | 90.3% | +10.8% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.3% | +58.8% |
| KENNEDY, SARAH JANE | 1 | 0.0% | +0.0% |
| BUNKER, AMY M | 1 | 29.1% | +45.6% |
| CHUNDURU, SURYAPRABHA | 1 | 53.3% | +17.2% |
| LU, FRANK WEI MIN | 1 | 62.7% | +67.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18959114 | PHASING AND PREPHASING CORRECTION OF BASE CALLING IN NEXT GENERATION SEQUENCING | COUSO, JOSE L | — |
| 18917561 | HIGH PERFORMANCE FLUORESCENCE IMAGING MODULE FOR GENOMIC TESTING ASSAY | BOOSALIS, FANI POLYZOS | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18654808 | COMPOSITIONS AND METHODS FOR SEQUENCING MULTIPLE REGIONS OF A TEMPLATE MOLECULE USING ENZYME-BASED REAGENTS | GIAMMONA, FRANCESCA FILIPPA | — |
| 18426101 | NUCLEIC ACID HYBRIDIZATION METHODS | KENNEDY, SARAH JANE | — |
| 18328650 | COMPOSITIONS AND METHODS FOR REDUCING BASE CALL ERRORS BY REMOVING DEAMINATED NUCLEOTIDES FROM A NUCLEIC ACID LIBRARY | BUNKER, AMY M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17705011 | ENGINEERED POLYMERASES | HUTSON, RICHARD G | 99d overdue |
| 17511046 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | CHUNDURU, SURYAPRABHA | 4d overdue |
| 18968535 | IMAGE REGISTRATION IN PRIMARY ANALYSIS | HSIEH, PING Y | — |
| 18917561 | HIGH PERFORMANCE FLUORESCENCE IMAGING MODULE FOR GENOMIC TESTING ASSAY | BOOSALIS, FANI POLYZOS | — |
| 18654808 | COMPOSITIONS AND METHODS FOR SEQUENCING MULTIPLE REGIONS OF A TEMPLATE MOLECULE USING ENZYME-BASED REAGENTS | GIAMMONA, FRANCESCA FILIPPA | — |
| 18571678 | Engineered Polymerases | HUTSON, RICHARD G | — |
| 18328650 | COMPOSITIONS AND METHODS FOR REDUCING BASE CALL ERRORS BY REMOVING DEAMINATED NUCLEOTIDES FROM A NUCLEIC ACID LIBRARY | BUNKER, AMY M | — |
| 17245670 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | LU, FRANK WEI MIN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1652 | 2 |
| 2664 | 1 |
| 2668 | 1 |
| 2884 | 1 |
| 1682 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18968535 | IMAGE REGISTRATION IN PRIMARY ANALYSIS | HSIEH, PING Y | 2664 | §103 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18959114 | PHASING AND PREPHASING CORRECTION OF BASE CALLING IN NEXT GENERATION SEQUENCING | COUSO, JOSE L | 2668 | §102Other | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18917561 | HIGH PERFORMANCE FLUORESCENCE IMAGING MODULE FOR GENOMIC TESTING ASSAY | BOOSALIS, FANI POLYZOS | 2884 | §103 | Non-Final OA | — | Pending | Oct 16, 2024 |
| 18654808 | COMPOSITIONS AND METHODS FOR SEQUENCING MULTIPLE REGIONS OF A TEMPLATE MOLECULE USING ENZYME-BASED REAGENTS | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18426101 | NUCLEIC ACID HYBRIDIZATION METHODS | KENNEDY, SARAH JANE | 1682 | §102§103§112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18571678 | Engineered Polymerases | HUTSON, RICHARD G | 1652 | §103§112DP | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18328650 | COMPOSITIONS AND METHODS FOR REDUCING BASE CALL ERRORS BY REMOVING DEAMINATED NUCLEOTIDES FROM A NUCLEIC ACID LIBRARY | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 17705011 | ENGINEERED POLYMERASES | HUTSON, RICHARD G | 1652 | §112DP | Final Rejection | 99d overdue | Pending | Mar 25, 2022 |
| 17511046 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | CHUNDURU, SURYAPRABHA | 1681 | DP | Final Rejection | 4d overdue | Pending | Oct 26, 2021 |
| 17245670 | MULTIVALENT BINDING COMPOSITION FOR NUCLEIC ACID ANALYSIS | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | — | Pending | Apr 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialElement Biosciences Inc. has 10 pending office actions as of October 2026, spread across 8 art units and 9 examiners.
Richard G Hutson has the most, with 2 of Element Biosciences Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
